SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is trending as renewed geopolitical concerns, particularly former President Trump's proposed tariffs on European nations, have triggered a broad risk-off sentiment and significant derivatives liquidations across the crypto market. The community is sharply divided, with many debating if this is a manipulated "bear trap" and a buying opportunity exacerbated by thin liquidity, while others anticipate further declines and question Bitcoin's safe-haven status.

MiMedx Group, Inc. is a therapeutic biologics company, which engages in the design, manufacture, and marketing of products, and tissue processing services. It serves the wound care, burn, surgical, orthopedic, spine, sports medicine, ophthalmic, and dental sectors of healthcare. Its biomaterial platform technologies include AmnioFix and EpiFix, a tissue allografts derived from amnion and chorion layers of human placental membrane, EpiCord and AmnioCord, a tissue allografts derived from umbilical cord tissue, and AmnioFill, a placental connective tissue matrix derived from the placental disc and other placental tissue. The company was founded on July 30, 1985 and is headquartered in Marietta, GA.

Mimedx Group Inc

Mimedx Group is trending due to significant upcoming Medicare policy changes in the wound care sector for 2025-2026, aimed at curbing fraud and reducing reimbursement for certain skin substitute products. The community is sharply divided, with some fearing substantial revenue losses for MDXG while others believe these reforms will eliminate unproven competitors and position the company for market share gains. This regulatory uncertainty is driving intense debate and volatility around the stock's future.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is trending due to its groundbreaking AI data center lease with AMD, signifying a strategic pivot from its core Bitcoin mining operations to high-performance computing infrastructure. The community is actively discussing the substantial multi-year revenue potential and significant expansion options this deal brings, viewing it as a catalyst to establish RIOT as a major player in the power-constrained AI sector.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

KENDU CRYPTO is trending due to a highly engaged community relentlessly building a permissionless brand with real-world products, including Kendu Spice and Energy drinks. Enthusiasts widely believe KENDU is a strong long-term play, emphasizing conviction and accumulation as the 'unstoppable' community aims for significant growth across multiple blockchain networks.

Kraken Robotics, Inc. engages in the design, manufacture, and sale of software-centric sensors, subsea batteries, thrusters and underwater robotic systems. It operates through the following geographical segments: Asia Pacific, Europe, Middle East and Africa, North America, and Other. The company was founded on May 14, 2008, and is headquartered in Mt. Pearl, Canada.

Kraken Robotics Inc

Kraken Robotics is trending amid news of substantial defense contracts and its pivotal role as a supplier for cutting-edge autonomous underwater vehicles, with community discussion frequently highlighting its integral connection to a prominent private defense technology firm. Investors are keenly watching Kraken's strong operational growth and expanding production capabilities, fueled by increasing global defense spending and expectations of future uplisting to major stock exchanges.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

The Ethereum ecosystem is drawing significant attention, primarily driven by the upcoming Fusaka network upgrade poised to enhance its scalability and efficiency, alongside increasing institutional interest and regulatory developments across the crypto sector. Many in the community are debating Ethereum's potential for a major breakout, emphasizing its role as a foundational layer for tokenization and decentralized finance. This optimism is balanced by ongoing concerns about market volatility and the impact of large liquidation events.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is experiencing heightened volatility amid community debate, largely fueled by delays in the Digital Asset Market Clarity Act and concerns over broader market manipulation. While many anticipate significant price drops, a strong segment of the community is actively buying dips, citing record staking activity and increasing institutional interest as reasons for their bullish outlook.

Endeavour Silver Corp. is a mineral company, which engages in the evaluation, acquisition, development and exploitation of precious metal properties in Mexico and Chile. The firm's projects include the Terronera property in Jalisco, the El Compas property, the Guanacevi Mine in Durango, Bolanitos Mines in Guanajuato, and the Parral project in Chihuahua, Mexico. The company was founded by Bradford James Cooke on March 11, 1981 and is headquartered in Vancouver, Canada.

Endeavour Silver Corp.

Endeavour Silver ($EXK) is trending as its Terronera mine achieves commercial production, adding to the broader bullish sentiment for silver, driven by anticipated supply constraints like China's upcoming export restrictions. Despite these strong fundamentals and a surging metal price, community discussions highlight significant frustration over the stock's perceived underperformance and alleged market manipulation. Nevertheless, investors maintain strong conviction, expecting a substantial re-rating as EXK's enhanced production capacity and the overall silver bull market ultimately drive its valuation higher.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is seeing a strong surge, fueled by positive business updates, including an improved financial outlook and significant progress in its flu vaccine and oncology pipeline. This comes as a favorable European patent ruling reduces legal concerns, sparking community discussion about a potential short squeeze given the substantial short interest and perceived undervaluation compared to its long-term therapeutic potential.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is a major talking point as investors grapple with renewed geopolitical tensions stemming from tariff threats on European allies. Community discussion is split between concerns over global trade stability and the market's historical resilience to similar political rhetoric. All eyes are on how the tech-heavy index will react to these developing headlines and potential policy shifts.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cogent Biosciences (NASDAQ:COGT) Shares Up 7.1% - Still a Buy?

Cogent Biosciences (NASDAQ:COGT) Stock Price Up 7.1% - Still a Buy...

Voya Investment Management LLC Increases Stock Position in Cogent Biosciences, Inc. $COGT

Voya Investment Management LLC increased its position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) by 110.0% during the 3rd quarter, according to its most recent filing with the...

Best Biotech Stocks To Follow Today - December 31st

Abivax, Danaher, and Cogent Biosciences are the three Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks are shares of companies that research, develop and...

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down Following Insider Selling

Cogent Biosciences (NASDAQ:COGT) Shares Gap Down Following Insider Selling...

Evan Kearns Sells 65,000 Shares of Cogent Biosciences (NASDAQ:COGT) Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Evan Kearns sold 65,000 shares of the company's stock in a transaction dated Friday, December 26th. The shares were sold at an average...

Insider Selling: Cogent Biosciences (NASDAQ:COGT) Insider Sells 65,000 Shares of Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Evan Kearns sold 65,000 shares of the company's stock in a transaction dated Friday, December 26th. The stock was sold at an average...

Cogent Biosciences (NASDAQ:COGT) Insider John Edward Robinson Sells 90,000 Shares

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider John Edward Robinson sold 90,000 shares of the company's stock in a transaction dated Friday, December 26th. The stock was sold at an...

Cogent Biosciences (NASDAQ:COGT) Insider Sells $3,198,245.40 in Stock

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) insider Jessica Sachs sold 82,642 shares of the company's stock in a transaction on Friday, December 26th. The stock was sold at an average...

Cogent Biosciences, Inc. (NASDAQ:COGT) Given Average Recommendation of "Moderate Buy" by Brokerages

Cogent Biosciences, Inc. (NASDAQ:COGT - Get Free Report) has been given a consensus rating of "Moderate Buy" by the fourteen analysts that are covering the firm, Marketbeat Ratings reports. One...

Squarepoint Ops LLC Purchases Shares of 101,518 Cogent Biosciences, Inc. $COGT

Squarepoint Ops LLC acquired a new position in shares of Cogent Biosciences, Inc. (NASDAQ:COGT - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the...

Cogent Biosciences, Inc. is a biotechnology company, which engages in the development of precision therapies for genetically defined diseases. It focuses on CGT9486, a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. The company was founded by Charles Wilson and Dario Campana in March 2014 and is headquartered in Waltham, MA.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.51	--	--	N/A
Q3 '25	-$0.54	-$0.50	7.94%	BEAT
Q2 '25	-$0.59	--	--	N/A
Q1 '25	-$0.60	-$0.64	-5.48%	MISSED
Q4 '24	-$0.60	--	--	N/A

COGT
Cogent Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest COGT News

COGTCogent Biosciences Inc